Opsens (TSX:OPS) 3-Year EBITDA Growth Rate : -244.80% (As of Aug. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Opsens 3-Year EBITDA Growth Rate?

Opsens's EBITDA per Share for the three months ended in Aug. 2023 was C$0.00.

During the past 3 years, the average EBITDA Per Share Growth Rate was -244.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Opsens was 69.30% per year. The lowest was -244.80% per year. And the median was -8.15% per year.

Competitive Comparison of Opsens's 3-Year EBITDA Growth Rate

For the Medical Instruments & Supplies subindustry, Opsens's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Opsens's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Opsens's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Opsens's 3-Year EBITDA Growth Rate falls into.

Opsens 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Opsens (TSX:OPS) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Opsens 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Opsens's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Opsens (TSX:OPS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Opsens Inc (TSX:OPS) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

750, Boulevard du Parc-Technologique, Quebec, QC, CAN, G1P 4S3

Website

https://www.opsens.com

OpSens Inc. is engaged in physiological measurements such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and in transcatheter aortic valve replacement (TAVR) in the structural heart market. It operates in two segments that are Medical and Industrial. In Medical segment it supplies an optical-based pressure guidewire (OptoWire), a guidewire used in the TAVR procedure (SavvyWire) and a wide range of miniature optical sensors to measure pressure and temperature to be used in a wide range of applications that can be integrated into other medical devices. Industrial segment includes developing, manufacturing and installing fibre optic sensing solutions for industrial applications. Majority of its revenue is derived from Medical segment.

Executives

Alan Milinazzo	Director
Robin Villeneuve	Senior Officer
Fiera Capital Corporation (formerly Fiera Sceptre Inc.)	10% Security Holder

Opsens (TSX:OPS) Headlines

No Headlines